Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TJ033721 |
Trade Name | |
Synonyms | ABL111|TJ-CD4B|CLDN18.2 x 4-1BB BsAb TJ-CD4B |
Drug Descriptions |
TJ033721 is a bispecific antibody that targets claudin 18.2 (CLDN18.2) and TNFRSF9 (4-1BB), which potentially results in activation of immune cells and antitumor activity (NCI Drug Dictionary). |
DrugClasses | CLDN18.2 Antibody 18 |
CAS Registry Number | NA |
NCIT ID | C180884 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TJ033721 | TJ033721 | 0 | 1 |